Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 22, 2022
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
[ Tue, Feb 22nd 2022
] - WOPRAI
Sun, February 20, 2022
[ Sun, Feb 20th 2022
] - WOPRAI
[ Sun, Feb 20th 2022
] - WOPRAI
Fri, February 18, 2022
[ Fri, Feb 18th 2022
] - WOPRAI
[ Fri, Feb 18th 2022
] - WOPRAI
[ Fri, Feb 18th 2022
] - WOPRAI
[ Fri, Feb 18th 2022
] - WOPRAI
[ Fri, Feb 18th 2022
] - WOPRAI
[ Fri, Feb 18th 2022
] - WOPRAI
[ Fri, Feb 18th 2022
] - WOPRAI
[ Fri, Feb 18th 2022
] - WOPRAI
[ Fri, Feb 18th 2022
] - WOPRAI
Bill Sutherland Maintained (AMN) at Strong Buy with Increased Target to $140 on, Feb 18th, 2022
Bill Sutherland of Benchmark, Maintained "AMN Healthcare Services, Inc." (AMN) at Strong Buy with Increased Target from $125 to $140 on, Feb 18th, 2022.
Bill has made no other calls on AMN in the last 4 months.
There are 2 other peers that have a rating on AMN. Out of the 2 peers that are also analyzing AMN, 0 agree with Bill's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Bill
- Nick Giovacchini of "Credit Suisse" Maintained at Buy with Increased Target to $139 on, Wednesday, November 17th, 2021
- Jeffrey Silber of "BMO Capital" Maintained at Buy with Increased Target to $127 on, Monday, November 8th, 2021
